Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · May 30, 2023

Glycemic Control With Novel Once-Weekly Basal Insulin Fc vs Insulin Degludec Therapy in Patients With Type 1 Diabetes

Diabetes Care


Additional Info

Diabetes Care
Novel Once-Weekly Basal Insulin Fc Achieved Similar Glycemic Control With a Safety Profile Comparable to Insulin Degludec in Patients With Type 1 Diabetes
Diabetes Care 2023 May 01;46(5)1052-1059, CM Kazda, JM Bue-Valleskey, J Chien, Q Zhang, E Chigutsa, W Landschulz, P Wullenweber, A Haupt, D Dahl

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading